Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Suzanne Kilany"'
Autor:
Sadollah Abedini, MD, PhD, Lasse Gøransson, MD, PhD, Elinor Cockburn, MSc, PhD, Suzanne Kilany, BSc, Hallvard Holdaas, MD, PhD
Publikováno v:
Transplantation Direct, Vol 4, Iss 2, p e338 (2018)
Background. This study investigated medication adherence in kidney transplant patients (KTPs) converted from immediate-release tacrolimus (IR-T) to prolonged-release tacrolimus (PR-T)-based immunosuppression in routine practice. Methods. Nonintervent
Externí odkaz:
https://doaj.org/article/86a781c852f24f459a2b752ccf828c78
Autor:
Suzanne Kilany, Ingela Franck Lissbrant, Karin Fagerlund, Johanna Svensson, Pär Stattin, Oskar Gauffin, Marie Hjälm-Eriksson
Publikováno v:
Scandinavian Journal of Urology. 55:1-8
To investigate time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer in Sweden, and the associated health economic impact.Registry study (NCT03619980) of the Prostate Cancer data Base Sweden with
Autor:
Mats Rosenlund, Sara Nordling, Aaron Levine, Jonas Wadström, Bengt von Zur-Mühlen, Viktor Wintzell, Suzanne Kilany
Publikováno v:
Annals of Transplantation
Background: Improved understanding of the impact of kidney transplantation on healthcare resource use/costs and loss of productivity could aid decision making about funding allocation and resources needed for the treatment of chronic kidney disease i
Autor:
Ingrid Karlsson, Susanne Gertsson, Suzanne Kilany, Marie Borggren, Pau Abrisqueta, Ana Carneiro, Raul Cordoba, Hans Hagberg, Mats Jerkeman, Santiago Mercadal, Jonathon B. Cohen, Juan-Manuel Sancho, Ingrid Teige, Linda Mårtensson, Björn Frendéus, Andres McAllister
Publikováno v:
Blood. 138:1354-1354
Introduction BI-1206 is a fully human anti-FcγRIIB antagonistic monoclonal antibody. BI-1206 enhances the activity of anti-CD20 antibodies such as rituximab by blocking the interaction of the anti-CD20 with this inhibitory receptor. This combination
Publikováno v:
The Aging Male. 20:266-276
Treating male lower urinary tract symptoms (LUTS) by targeting the prostate would have limited effect on overactive bladder (OAB) symptoms. This study assessed perceived symptoms and quality of life (QoL) of male patients with OAB treated with an α-
Publikováno v:
Scandinavian journal of urology. 53(4)
Aim: To describe treatment patterns in Denmark, Norway and Sweden for patients receiving overactive bladder (OAB) pharmacotherapy. Methods: This was a prospective, multinational, registry-based study involving three nationwide prescribed drug registr
Publikováno v:
Nephrology Dialysis Transplantation. 34
Publikováno v:
Transplantation Direct, Vol 4, Iss 2, p e338 (2018)
Transplantation Direct
Transplantation Direct
Background. This study investigated medication adherence in kidney transplant patients (KTPs) converted from immediate-release tacrolimus (IR-T) to prolonged-release tacrolimus (PR-T)-based immunosuppression in routine practice. Methods. Nonintervent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b35194dad08a11cb08f81a68b0bd8dcb
http://hdl.handle.net/10852/67579
http://hdl.handle.net/10852/67579
Publikováno v:
Value in Health. 22:S537